Zwitterionic-Modified Starch-Based Stealth Micelles for Prolonging Circulation Time and Reducing Macrophage Response

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Nanoparticles offer potential for enhanced drug delivery and diagnostics.
• Protein adsorption on nanoparticles in blood leads to rapid clearance, hindering therapeutic efficacy.
• Overcoming blood's complexity is crucial for successful in vivo nanoparticle applications.

Purpose of the Study:

• To design and synthesize a novel starch derivative for improved nanoparticle drug delivery.
• To create self-assembling "stealth" micelles with enhanced stability and prolonged circulation.
• To evaluate the protein resistance, hemocompatibility, and in vivo performance of the novel micelles.

Main Methods:

• Synthesis of a starch derivative (SB-ST-OC) incorporating zwitterionic sulfobetaine (SB) and octane (OC) groups.
• Self-assembly into "stealth" SSO micelles.
• Assessment of protein resistance, hemocompatibility, macrophage activation, and pharmacokinetics with doxorubicin (DOX).

Main Results:

• SSO micelles demonstrated excellent protein resistance and hemocompatibility.
• Reduced macrophage activation and prolonged blood circulation time were observed.
• Pharmacokinetic studies showed increased plasma area under the concentration curve (AUC) and elimination half-life (T1/2) for DOX-loaded SSO micelles.

Conclusions:

• The novel starch derivative effectively forms "stealth" micelles with superior protein resistance and biocompatibility.
• These SSO micelles exhibit reduced immune activation and extended in vivo circulation.
• The synthesized starch derivative is a promising carrier for hydrophobic drugs requiring long-term circulation.